RAPT Therapeutics (RAPT) Accounts Payables (2020 - 2024)
Historic Accounts Payables for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $1.4 million.
- Therapeutics' Accounts Payables fell 7394.75% to $1.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 million, marking a year-over-year decrease of 7394.75%. This contributed to the annual value of $5.2 million for FY2023, which is 5381.87% up from last year.
- As of Q3 2024, Therapeutics' Accounts Payables stood at $1.4 million, which was down 7394.75% from $2.7 million recorded in Q2 2024.
- Therapeutics' 5-year Accounts Payables high stood at $8.9 million for Q1 2023, and its period low was $1.4 million during Q3 2024.
- Over the past 5 years, Therapeutics' median Accounts Payables value was $3.4 million (recorded in 2022), while the average stood at $3.7 million.
- Its Accounts Payables has fluctuated over the past 5 years, first soared by 36182.85% in 2023, then crashed by 7394.75% in 2024.
- Therapeutics' Accounts Payables (Quarter) stood at $2.4 million in 2020, then fell by 16.11% to $2.0 million in 2021, then surged by 68.33% to $3.4 million in 2022, then surged by 53.82% to $5.2 million in 2023, then crashed by 73.34% to $1.4 million in 2024.
- Its last three reported values are $1.4 million in Q3 2024, $2.7 million for Q2 2024, and $6.8 million during Q1 2024.